Search results

Pharmacogenomics is the study of how genetic variation affects responses to drugs. This includes both the efficacy and safety of drugs.

Responding to the future elective recovery plan, Sam Rodger, Assistant Director, Policy and Strategy of the NHS Race and Health Observatory, said:

Teaching curricula widely studied by healthcare professionals working across the NHS are under review in an effort to improve patient care and reduce racialised health disparities.

On 6 August, we will be launching a tender to commission the creation of a new, open-access resource enabling community participation and co-production with Black, Asian, and minoritised ethnic patients, communities, and staff.

An opportunity to work with us to explore and quantify the economic costs of racism and ethnic inequity in health and healthcare in England.

An opportunity to work with us to review routes of access for dementia diagnosis and care services in England.

How you can get in touch with us, where to find us, and how to stay informed about the work we do.

Familial hypercholesterolemia is a disorder that is typically inherited from a parent causing high cholesterol levels.  Without treatment, it can cause early heart attacks along with a higher risk of heart disease.

A recent parliamentary inquiry into avoidable deaths and failures of care for sickle cell patients in secondary care identified that too often acute painful sickle episodes are poorly managed by the NHS.  It recommended that the NHS Race and Health Observatory (NHSRHO) undertake a study into sickle cell care in relation to race and ethnicity.

A recent parliamentary inquiry into avoidable deaths and failures of care for sickle cell patients in secondary care identified inadequate investment in sickle cell care. It recommended that the NHS Race and Health Observatory (NHSRHO) undertake a study into sickle cell care in relation to race and ethnicity.